Concepedia

Author

N. Malamos

General-Maternity District Hospital Helena Venizelou

Also Known As

N A Malamos, N Malamos, N. A. Malamos, N. Malamos, N.A. Malamos, Nicholaos A. Malamos

48

Publications

1.1K

Citations

15

H-Index

27

Concepts

All Affiliations

General-Maternity District Hospital Helena VenizelouForthnet (Greece)University Hospital of HeraklionMetaxa HospitalUniversity of Crete
NM

About

N. Malamos is an author at General-Maternity District Hospital Helena Venizelou specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

444

2

Natural Sciences

1

1

16

3

Biochemistry

1

1

16

4

Cell Biology

1

1

17

5

Immunology

1

1

103

N. Malamos

×

17

Publications

1K

Citations

15

H-Index

YearCitations

Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance

Aliki Stathopoulou, Ioannis G. Vlachonikolis, D. Mavroudis,

Journal of Clinical Oncology

2002

340

Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)

D. Mavroudis, Emmanouil Saloustros, N. Malamos,

Annals of Oncology

2015

162

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

Nikolaos Xenidis, Ioannis G. Vlachonikolis, D. Mavroudis,

Annals of Oncology

2003

103

Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study.

Mata Fafouti, Thomas Paparrigopoulos, Y. Zervas,

PubMed

2011

67

Pregnancy and Offspring after the Appearance of Breast Cancer

N. Malamos, George P. Stathopoulos, Antonios Keramopoulos,

Oncology

1996

64

Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study

D. Antonadou, E. Cardamakis, Marco Puglisi,

European Journal of Cancer

2001

45

Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens

Christos Kosmas, C Panopoulos, Maria Vadiaka,

European Journal of Cancer

2001

37

Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

Christos Kosmas, N. Mylonakis, Georgios Tsakonas,

British Journal of Cancer

2009

36

Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)

Dimitriοs Mavroudis, Alexios Matikas, N. Malamos,

Annals of Oncology

2016

32

Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.

G. Stathopoulos, S. Rigatos, N. Malamos

Oncology Reports

1999

26

Page 1